Schedule 13G ownership disclosure

MEREO BIOPHARMA GROUP PLC

Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares · CUSIP: 589492107

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Frazier Life Sciences Public Fund, L.P.

    Shares: 0.00 · Class: 0.0%

  • FHMLSP, L.P.

    Shares: 0.00 · Class: 0.0%

  • FHMLSP, L.L.C.

    Shares: 0.00 · Class: 0.0%

  • Frazier Life Sciences X, L.P.

    Shares: 0.00 · Class: 0.0%

  • FHMLS X, L.P.

    Shares: 0.00 · Class: 0.0%

  • FHMLS X, L.L.C.

    Shares: 0.00 · Class: 0.0%

  • Frazier Life Sciences XI, L.P.

    Shares: 0.00 · Class: 0.0%

  • FHMLS XI, L.P.

    Shares: 0.00 · Class: 0.0%

  • FHMLS XI, L.L.C.

    Shares: 0.00 · Class: 0.0%

  • James N. Topper

    Shares: 0.00 · Class: 0.0%

  • Patrick J. Heron

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001231919-26-000157
Form type
SCHEDULE 13G/A
Filer
Frazier Life Sciences Public Fund, L.P.
CIK
CIK 1863769
Filed
Feb 13, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub